when were glp-1 agonists approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! Glucagon-Like Peptide (GLP)-1 Agonists Weight

So I think there's a lot of heterogeneity or variety in patients

C/I, Control group/Intervention group

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: A multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

The median time elapsed from the earliest patent filing date within a given product to the expiration date of the last-to-expire patent or exclusivity on that product was 31.9 years (IQR: 29.9-36.6)

Recent systematic evaluations found no higher rate of UTIs with GLP 1 therapy compared with other diabetes medications

doi: 10.1515/BC.2008.019